Drug Shortage Report for SANDOZ RIVAROXABAN

Last updated on 2025-04-22

Report ID 245211
Drug Identification Number 02537877
Brand name SANDOZ RIVAROXABAN
Common or Proper name RIVAROXABAN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RIVAROXABAN
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100FCT
ATC code B01AF
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-12-09
Estimated end date 2025-06-06
Actual end date
Shortage status Actual shortage
Updated date 2025-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-04-22 French Compare
v9 2025-04-22 English Compare
v8 2025-04-14 French Compare
v7 2025-04-14 English Compare
v6 2025-03-03 French Compare
v5 2025-03-03 English Compare
v4 2024-12-16 French Compare
v3 2024-12-16 English Compare
v2 2024-12-10 French Compare
v1 2024-12-10 English Compare

Showing 1 to 10 of 10